ArticleJournal of experimental & clinical cancer research : CR2025

MRPL21-PARP1 axis promotes cisplatin resistance in head and neck squamous cell carcinoma by inhibiting autophagy through the PI3K/AKT/mTOR signaling pathway.

Rui Guan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.